Kamiar Zomorodian

Kamiar Zomorodian


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Medical Mycology
Verified
Journal Article
Open access
PDF file
KZKamiar Zomorodian
Kamiar Zomorodian
NHNeda Nejabat Haghighi
Neda Nejabat Haghighi
NRNaeem Rajaee
Naeem Rajaee
KPKeyvan Pakshir
Keyvan Pakshir
BTBita Tarazooie
Bita Tarazooie
MVMehrdad Vosoghi
Mehrdad Vosoghi
Candida species are considered the primary causative agents of denture stomatitis, but their role in colonization and disease in denture wearers remai

13 December 2012 in ISRN Pharmaceutics
Verified
Journal Article
Open access
PDF file
MSMohammad Jamal Saharkhiz
Mohammad Jamal Saharkhiz
MMMarjan Motamedi
Marjan Motamedi
KZKamiar Zomorodian
Kamiar Zomorodian
KPKeyvan Pakshir
Keyvan Pakshir
RMRamin Miri
Ramin Miri
KHKimia Hemyari
Kimia Hemyari
Variations in quantity and quality of essential oil (EO) from the aerial parts of cultivatedMentha piperitawere determined. The EO of air-dried sample was obtained by a hydrodistillation method and analyzed by a gas chromatography/mass spectrometry (GC/MS). The antifungal activity of the EO was investigated by broth microdilution methods as recommended by Clinical and Laboratory Standards Institute. A biofilm formation inhibition was measured by using an XTT reduction assay. Menthol (53.28%) was the major compound of the EO followed by Menthyl acetate (15.1%) and Menthofuran (11.18%). The EO exhibited strong antifungal activities against the examined fungi at concentrations ranging from 0.12 to 8.0 μL/mL. In addition, the EO inhibited the biofilm formation ofCandida albicansandC. dubliniensisat concentrations up to 2 μL/mL. Considering the wide range of the antifungal activities of the examined EO, it might be potentially used in the management of fungal infections or in the extension of the shelf life of food products.

1 January 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
KZKamiar Zomorodian
Kamiar Zomorodian
SPSeyedmohammad Pourshahid
Seyedmohammad Pourshahid
ASArman Sadatsharifi
Arman Sadatsharifi
PMPouyan Mehryar
Pouyan Mehryar
KPKeyvan Pakshir
Keyvan Pakshir
AMAli Arabi Monfared
Ali Arabi Monfared
Currently, researchers turn to natural processes such as using biological microorganisms in order to develop reliable and ecofriendly methods for the synthesis of metallic nanoparticles. In this study, we have investigated extracellular biosynthesis of silver nanoparticles using fourAspergillusspecies includingA. fumigatus,A. clavatus,A. niger,andA. flavus. We have also analyzed nitrate reductase activity in the studied species in order to determine the probable role of this enzyme in the biosynthesis of silver nanoparticles. The formation of silver nanoparticles in the cell filtrates was confirmed by the passage of laser light, change in the color of cell filtrates, absorption peak at 430 nm in UV-Vis spectra, and atomic force microscopy (AFM). There was a logical relationship between the efficiencies of studiedAspergillusspecies in the production of silver nanoparticles and their nitrate reductase activity.A. fumigatusas the most efficient species showed the highest nitrate reductase activity among the studied species whileA. flavusexhibited the lowest capacity in the biosynthesis of silver nanoparticles which was in accord with its low nitrate reductase activity. The present study showed thatAspergillusspecies had potential for the biosynthesis of silver nanoparticles depending on their nitrate reductase activity.

29 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Javad MottaghipishehJavad Mottaghipisheh
Javad Mottaghipisheh
HTHadi Taghrir
Hadi Taghrir
ADAnahita Boveiri Dehsheikh
Anahita Boveiri Dehsheikh
KZKamiar Zomorodian
Kamiar Zomorodian
CICambyz Irajie
Cambyz Irajie
AIAida Iraji
Aida Iraji
Many flavonoids, as eminent phenolic compounds, have been commercialized and consumed as dietary supplements due to their incredible human health benefits. In the present study, a bioactive flavone glycoside linarin (LN) was designated to comprehensively overview its phytochemical and biological properties. LN has been characterized abundantly in the Cirsium, Micromeria, and Buddleja species belonging to Asteraceae, Lamiaceae, and Scrophulariaceae families, respectively. Biological assessments exhibited promising activities of LN, particularly, the remedial effects on central nervous system (CNS) disorders, whereas the remarkable sleep enhancing and sedative effects as well as AChE (acetylcholinesterase) inhibitory activity were highlighted. Of note, LN has indicated promising anti osteoblast proliferation and differentiation, thus a bone formation effect. Further biological and pharmacological assessments of LN and its optimized semi-synthetic derivatives, specifically its therapeutic characteristics on osteoarthritis and osteoporosis, might lead to uncovering potential drug candidates.

12 December 2019 in Medical Mycology
Verified
Journal Article
Open access
PDF file
AAAmir Arastehfar
Amir Arastehfar
FDFarnaz Daneshnia
Farnaz Daneshnia
AHAhmed Hafez
Ahmed Hafez
SKSadegh Khodavaisy
Sadegh Khodavaisy
MNMohammad-Javad Najafzadeh
Mohammad-Javad Najafzadeh
TBTeun Boekhout
Teun Boekhout
Candida tropicalis is one of the major candidaemia agents, associated with the highest mortality rates among Candida species, and developing resistance to azoles. Little is known about the molecular mechanisms of azole resistance, genotypic diversity, and the clinical background of C. tropicalis infections. Consequently, this study was designed to address those questions. Sixty-four C. tropicalis bloodstream isolates from 62 patients from three cities in Iran (2014–2019) were analyzed. Strain identification, antifungal susceptibility testing, and genotypic diversity analysis were performed by MALDI-TOF MS, CLSI-M27 A3/S4 protocol, and amplified fragment length polymorphism (AFLP) fingerprinting, respectively. Genes related to drug resistance (ERG11, MRR1, TAC1, UPC2, and FKS1 hotspot9s) were sequenced. The overall mortality rate was 59.6% (37/62). Strains were resistant to micafungin [minimum inhibitory concentration (MIC) ≥1 μg/ml, 2/64], itraconazole (MIC > 0.5 μg/ml, 2/64), fluconazole (FLZ; MIC ≥ 8 μg/ml, 4/64), and voriconazole (MIC ≥ 1 μg/ml, 7/64). Pan-azole and FLZ + VRZ resistance were observed in one and two isolates, respectively, while none of the patients were exposed to azoles. MRR1 (T255P, 647S), TAC1 (N164I, R47Q), and UPC2 (T241A, Q340H, T381S) mutations were exclusively identified in FLZ-resistant isolates. AFLP fingerprinting revealed five major and seven minor genotypes; genotype G4 was predominant in all centers. The increasing number of FLZ-R C. tropicalis blood isolates and acquiring FLZ-R in FLZ-naive patients limit the efficiency of FLZ, especially in developing countries. The high mortality rate warrants reaching a consensus regarding the nosocomial mode of C. tropicalis transmission.

1 March 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SBSajjad Barzegar
Sajjad Barzegar
MZMohammad Reza Zare
Mohammad Reza Zare
FSFatemeh Shojaei
Fatemeh Shojaei
ZZZahra Zareshahrabadi
Zahra Zareshahrabadi
OKOmid Koohi-Hosseinabadi
Omid Koohi-Hosseinabadi
MKMohammad Khorram
Mohammad Khorram